Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • AKroxy
    Member
    • May 2009
    • 20

    bait design for seqCapture

    I have questions about developing baits for sequence capture to use in population genetics of 2 very closely related species.

    We have no genomic resources for our organism (a sedge) or anything in the very large genus.

    However, we did a *very* low coverage whole genome sequencing run from our species of interest on the miSeq - we ended up with about 1/10x coverage of the genome (~250bp fragments).
    I want to use these unassembled reads to develop baits. We want to target random regions throughout the genome.

    I had never intended to assemble this data - I didn't see a need.

    After trimming, I had intended to use blast to remove as many undesirable sequences as possible (chloroplast, mitochondria, virus, bacteria, and things that blast to know repetitive DNA), and then randomly choose ~10,000 unassembled reads for bait design (designed by mycroArray/myBaits).

    However, my husband, the bioinformatics guy, thinks it is crazy to design baits from unassembled sequence.

    He thinks we need more sequence data, so we can at least partially assemble the genome before selecting regions for bait design. He argues that we can't trust unassembled reads because in a typical assembly (with more data) ~50% of reads can't be assembled, so they must be garbage - implying that from my approach 50% of the baits will be garbage.

    I realize that we could do RADseq or some variant, but prefer not to, due to possible bias (low number of individuals per locus).

    My question is whether we need to get more sequence data for a partial assembly, or if my approach is reasonable.

    Thanks for any input!
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    I think that targeting genic regions would be a better approach because they would be more conserved between or among species than intergenic region. To do this, assembly and a BLAST to identify contigs from coding region of genome is essential.

    Comment

    • AKroxy
      Member
      • May 2009
      • 20

      #3
      thanks for your response. Yes, most people doing seqCap are using transcriptome data for bait design. But those people are interested in phylogenetics. We're interested in within-species diversity (or btw 2 very closely related species), so we don't really want conserved regions - though with 5-10,000 baits, even conserved regions would probably give enough snps to see if the 2 species are different from each other.
      My husband thinks that blasting all of the unassembled reads is unreasonable bc there are millions of reads. but metagenomics people seem to do that

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:41 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...